No description available.

No description available.

No description available.

Echinacea which belongs to Asteraceae family has been used as a traditional remedy by the North American Indians for many years. During the past decades, many biological, pharmacological and chemical papers have demonstrated that Echinacea acts as an immune stimulator and the primary active components are considered to be polysaccharides and glycoproteins, alkamides and caffeic acid derivatives.

This thesis, which is divided into four chapters, represents an account on the isolation, identification and the assessment of bioactivity of cytotoxic compounds from the genus Centaurea (Family: Asteraceae alto Compositae), a large genus of about 500 species. The first three chapters deal with an introduction of natural products and Centaurea species, followed by the isolation and characterisation of compounds from twelve Centaurea species. The last chapter describes the bioactivities of extracts and isolated compounds from these species. A total of 45 compounds were isolated from twelve Centaurea species, and only C. americana, C. cyanus, C. dealbata and C. macrocephala had previously been studied. Four of these are novel compounds. Four lignans arctiin, matairesinoside, matairesinol and lappaol A were isolated fromthe methanol extract of C. macrocephala seeds. Arctiin and matairesinoside were also isolated from the methanol extract of C. americana, C. bornmuel/eri, C. dealbata, C. huber-morathii, C. mucronifera, C. pamphylica, C. schischkinii and C. urvillei. The methanol extract of C. americana also afforded 20-hydroxyecdysone, 24-hydroxyecdysone, lappaol A, arctigenin and a novel compound, 3"-O-caffeoyl(9"'→3")-arctiin. The methanol extract of C. cyanus produced lariciresinol 4-0-B-D-glucoside, berchemol, moschamine and cis-moschamine. Arctigenin, astragalin, afzelin, matairesinol and a novel indole alkaloids, schischkiniin, were isolated from the methanol extract of C. schischkinii. Extract from C. bornmuelleri afforded arctigenin, astragalin, afzelin and matairesinol. The methanol extract of C. mon/ana yielded berchemol, berchemol 4'-O-B-D-glucoside, p-coumaroylquinic acid, cis-pcoumaroylquinic acid, pinoresinol, pinoresinol mono methyl ether, pinoresinol dimethyl ether, pinoresinol 4-0-B-D-glucoside, pinoresinol 4,4'di-0-B-D-glucoside, pinoresinol 4-0-apiose-(1→2)-B-D-glucoside, centcyamine, cis-centcyamine, N-(4-hydroxycinnamoyl)-5-hydroxytryptamine, cis-N-(4-hydroxycinnamoyl)-5-hydroxytryptamine, moschamine, cis-moschamine, tryptamine and two novel compounds, flavanone-apiose-glucuronic acid and montamine. C. gigantea afforded arctiopicrin, 8-0-(4-hydroxy-3-methylbutanoyl)-salonitenolide, chlorogenic acid, cirsiliol, isoquercetrin, orientin, isoorientin and 4"-hydroxybenzoyl-isoorientin. General toxicity, cytotoxicity and antioxidant activity of the extracts and isolated compounds were evaluated, respectively, by the brine shrimp lethality assay, MTT assay on human colon cancer cell line (CaCo-2) and DPPH assay. Among all the species, the methanol extract of C. bornmuelleri, C. gigantea, C. huber-morathii and C. montana were the most toxic extracts in brine shrimp lethality and MTT assay. Arctigenin (IC50=7.0 mM), matairesinol, montamine (IC50=43.9 mM) and lappol A, schischkiniin, arctiopicrin (IC50=8.5 mM) and 8-0-(4-hydroxy-3-methylbutanoyl)-salonitenolide (IC50=26.4 mM) showed higher cytotoxicity against MTT assay. Matairesinoside (IC50=2.2 x 10-3 mg/mL), matairesinol (IC50=2.0 x 10-3 mg/mL) and schischkiniin (lC50=3.8 x 10-3 mg/mL) exhibited significant free radical scavenging activities towards DPPH assay.

The fatty acid amides, a structurally diverse endogenous congener of molecules active in cell signaling, may prove to have diverse activity due to their interface with a number of receptor systems, including, but not limited to cannabinoid receptor 2 (CB2) and PPARγ. Select extracts of Echinacea spp. contain the fatty acid amides known as alkylamides. These extracts were a previously popular remedy relied on by U.S. physicians, one of the top sellers in the natural products industry and are currently a frequently physician prescribed remedy in Germany. In the series of experiments contained within, Galenic ethanolic extracts of Echinacea spp. root were used for the quantification, identification, degradation and bioactivity studies. On extraction, depending on the ratio of plant to solvent and fresh or dry, the data indicate that there is variability in the alkylamide classes extracted. For example the acetylene alkylamides appear to extract under different concentrations, as well as degrade faster than the olefinic alkylamides. In addition, the alkylamides are found to degrade significantly in both cut/sift and powdered forms of echinacea root. Human liver microsome oxidation of the major alkylamide dodeca-2E,4E,8Z,10Z-tetraenoic acid isobutylamide generate hydroxylated, caboxylated and epoxidized metabolites. The carboxylated metabolite has, thus far, shown different immune activity than the native tetraene isobutylamide. Bioactivity studies, based on cytokine modulation of the alkylamides have been assumed to be due to a classic CB2 response. However, the results of experiments contained herein suggest that IL-2 inhibition by the alkylamide undeca-2E-ene-8,10-diynoic acid isobutylamide, which does not bind to CB2, is due to PPARγ activation. These data, combined with data generated by other groups, suggest that the alkylamides of Echinacea spp. are polyvalent in effect, in that they modulate multiple biochemical pathways.